Edward Arrowsmith, MD, describes the value of using clinical pathways in NSCLC therapy and how they are used at his institution, including their multiple sites of care. Edward Arrowsmith, MD: We think ...
As healthcare becomes more entrenched in the digital revolution, the need for an approved set of protocols for care delivery — clinical pathways — is becoming increasingly critical. Clinical pathways, ...
A panel of experts discuss the value of clinical pathways in MM disease management. Ryan Haumschild, PharmD, MS, MBA: Let’s talk about clinical pathways. We’ve seen pathways continue to emerge. One ...
In the realm of oncology, the advent of clinical pathways has gained substantial traction in the past two decades as the increasing cost and complexity of cancer care demanded structured, ...
Linda Bosserman, M.D., joined City of Hope in Los Angeles nine years ago as a medical oncologist specializing in breast cancer and value-based care. During her 26 years in private practice, prior to ...
If we were to convene a panel of healthcare experts to choose a goal that holds the promise of being both achievable and influential at improving the value of healthcare, it may very well be the ...
Cancer clinical trials can benefit current and future patients; however, Black patients, rural residents, and patients living in disadvantaged areas are often underrepresented. Using an adapted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback